JP2010513551A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513551A5 JP2010513551A5 JP2009543060A JP2009543060A JP2010513551A5 JP 2010513551 A5 JP2010513551 A5 JP 2010513551A5 JP 2009543060 A JP2009543060 A JP 2009543060A JP 2009543060 A JP2009543060 A JP 2009543060A JP 2010513551 A5 JP2010513551 A5 JP 2010513551A5
- Authority
- JP
- Japan
- Prior art keywords
- prostaglandin
- amide
- ether
- ester
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87044406P | 2006-12-18 | 2006-12-18 | |
| PCT/US2007/087042 WO2008076703A1 (en) | 2006-12-18 | 2007-12-11 | Methods and compositions for treating gastrointestinal disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014168689A Division JP2014210824A (ja) | 2006-12-18 | 2014-08-21 | 胃腸疾患の治療方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010513551A JP2010513551A (ja) | 2010-04-30 |
| JP2010513551A5 true JP2010513551A5 (enExample) | 2011-02-03 |
Family
ID=39059771
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Ceased JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
| JP2014168689A Ceased JP2014210824A (ja) | 2006-12-18 | 2014-08-21 | 胃腸疾患の治療方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014168689A Ceased JP2014210824A (ja) | 2006-12-18 | 2014-08-21 | 胃腸疾患の治療方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100081631A1 (enExample) |
| EP (3) | EP2120962A1 (enExample) |
| JP (2) | JP2010513551A (enExample) |
| AU (1) | AU2007334038A1 (enExample) |
| BR (1) | BRPI0721067A2 (enExample) |
| CA (1) | CA2690273A1 (enExample) |
| WO (1) | WO2008076703A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| EP2522343A1 (en) | 2006-03-28 | 2012-11-14 | Javelin Pharmaceuticals, Inc. | Formulations of Low Dose Diclofenac and Beta-Cyclodextrin |
| US20090012165A1 (en) * | 2007-07-03 | 2009-01-08 | Sucampo Ag | Pharmaceutical combination of nsaid and prostaglandin compound |
| CN103068382A (zh) * | 2010-07-30 | 2013-04-24 | 阿勒根公司 | 用于皮肤修复的化合物和方法 |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| RU2586040C1 (ru) * | 2014-12-25 | 2016-06-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства Здравоохранения Российской Федерации (ГБОУ ВПО НижГМА Минздрава России) | Способ диагностики идиопатической язвенной болезни желудка и двенадцатиперстной кишки |
| CN107849072B (zh) | 2015-06-12 | 2020-12-15 | 西蒙弗雷泽大学 | 酰胺连接的ep4激动剂-二膦酸盐化合物及其用途 |
| NL2018407B1 (en) * | 2017-02-22 | 2018-09-17 | Skytree B V | Improved process and apparatus for the removal of metabolic carbon dioxide from a confined space |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110298A (en) * | 1993-07-13 | 1999-04-11 | Brann Mark Robert | Identification of ligands by selective amplification of cells transfected with receptors |
| EP1114816A4 (en) | 1998-09-14 | 2002-09-04 | Ono Pharmaceutical Co | SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES- $ g (V) AND MEDICINAL PRODUCTS CONTAINING THEM AS ACTIVE INGREDIENT |
| EA200300379A1 (ru) * | 2000-11-27 | 2003-08-28 | Пфайзер Продактс Инк. | Селективные агонисты рецептора ep4 в лечении остеопороза |
| AU2003211574A1 (en) * | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| WO2006047476A2 (en) * | 2004-10-26 | 2006-05-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7893107B2 (en) * | 2005-11-30 | 2011-02-22 | Allergan, Inc. | Therapeutic methods using prostaglandin EP4 agonist components |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
-
2007
- 2007-12-11 JP JP2009543060A patent/JP2010513551A/ja not_active Ceased
- 2007-12-11 BR BRPI0721067-1A patent/BRPI0721067A2/pt not_active IP Right Cessation
- 2007-12-11 AU AU2007334038A patent/AU2007334038A1/en not_active Abandoned
- 2007-12-11 WO PCT/US2007/087042 patent/WO2008076703A1/en not_active Ceased
- 2007-12-11 EP EP07855057A patent/EP2120962A1/en not_active Ceased
- 2007-12-11 EP EP12188643A patent/EP2548559A1/en not_active Withdrawn
- 2007-12-11 CA CA2690273A patent/CA2690273A1/en not_active Abandoned
- 2007-12-11 EP EP12159850A patent/EP2465506A1/en not_active Withdrawn
- 2007-12-11 US US12/519,215 patent/US20100081631A1/en not_active Abandoned
-
2014
- 2014-08-21 JP JP2014168689A patent/JP2014210824A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009017716A3 (en) | Pulsatile gastric retentive dosage forms | |
| EP2283843A3 (en) | Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) | |
| EP2157919A4 (en) | ENDOSCOPIC RELEASE DEVICES AND METHOD | |
| JP2001515033A5 (enExample) | ||
| NO20092398L (no) | Krystallinske former av solvatisert ilaprazol | |
| MA29860B1 (fr) | Modulateurs du metabolisme et le traitement de troubles s'y rapportant | |
| JP2006518751A5 (enExample) | ||
| ZA200810125B (en) | Pharmaceutical combination comprising 3- (3-dimethy-lamin0-1-ethyl-2-methyl-pr0pyl)-phenol and an NSAID | |
| JP2010534236A5 (enExample) | ||
| KR101333753B1 (ko) | 세포 손상 및 염증 질환의 치료 또는 예방용 약학 조성물 | |
| JP2014210824A5 (enExample) | ||
| WO2010114425A3 (ru) | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки | |
| IL198891A (en) | Α2δ and nsaids ligands for use in the treatment of lower urinary tract irregularities | |
| JP2011157375A5 (enExample) | ||
| NO20071244L (no) | Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten | |
| Pacifici | Clinical pharmacology of esomeprazole in infants and children | |
| BRPI0713338A2 (pt) | formulaÇÕes galÊnicas de compostos orgÂnicos | |
| Murakami et al. | Tu1056 a phase 3, double-blind study of a triple therapy with TAK-438, amoxicillin, and clarithromycin as first line eradication of H. pylori and a triple therapy with TAK-438, amoxicillin, and metronidazole as second Line eradication of H. pylori | |
| WO2007064664A3 (en) | Prostaglandin ep4 agonists for the treatment of gastric conditions | |
| US8747920B2 (en) | Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic-analgesic drug and proton pump inhibitor | |
| RU2015106931A (ru) | Лекарственное средство от гастроэзофагеальной рефлюксной болезни | |
| JP2006516279A5 (enExample) | ||
| ES2306905T3 (es) | Utilizacion del tenatoprazol para el tratamiento del reflujo gastroesofagico. | |
| AU2009223644A1 (en) | Therapy for disorders of the proximal digestive tract | |
| Sydenham | Farmacología de los analgésicos |